Clinical Trials - Phase III
Filter News
Found 22,560 articles
-
Amgen Vectibix Trial Halted Over "Inferior Outcomes"
11/8/2011
-
Abbott Laboratories Reports Five-Year Data for HUMIRA(R) (Adalimumab) in Ankylosing Spondylitis
11/8/2011
-
Outstanding Interim Results of Stentys International Clinical Study of 600 Heart Attack Patients
11/8/2011
-
Boehringer Ingelheim Pharmaceuticals, Inc. Release: BI 201335 Demonstrates Potential toShorten HCV Treatment Duration While Achieving High Sustained Virological Response Rates in Difficult to Treat Patients
11/8/2011
-
Bristol-Myers Squibb Company Release: Phase IIIb Comparison of BARACLUDE® (entecavir) Monotherapy Versus BARACLUDE Plus Tenofovir Combination Shows No Statistical Difference Between Study Arms
11/8/2011
-
NPS Pharmaceuticals, Inc. Hormone-Replacement Drug Works in Phase III Study
11/7/2011
-
Pall Corporation Introduces Acrodisc® MS Syringe Filter Certified for Low LCMS Extractables
11/7/2011
-
UCB, Inc. Release: New RAPID 1 Post-Hoc Analysis Showed Early Response to Cimzia(R) (certolizumab pegol) at Week 12 was Predictive of Week 52 Response
11/7/2011
-
Abbott Laboratories Presents HUMIRA(R) (Adalimumab) Phase 3 Study Results for Patients with Active Non-Radiographic Axial Spondyloarthritis
11/7/2011
-
Gilead Sciences, Inc. and Cardiovascular Research Foundation Initiate Phase 3 Clinical Trial with Ranolazine in Patients Who Have Undergone PCI with a History of Prior Chronic Angina
11/7/2011
-
Sunovion Pharmaceuticals Inc.’s Investigational Ciclesonide Nasal Aerosol in an HFA Propellant, Demonstrated Positive Results in Patients with Perennial Allergic Rhinitis
11/7/2011
-
Fibrocell Science, Inc. Release: Studies Show LAVIV™ (azficel-T) Effectively Improves the Appearance of Smile Line Wrinkles
11/7/2011
-
Novartis Corporation Phase III Study Shows ACZ885 Helped Substantially Reduce Steroid Use in 45% of Patients With Serious Form of Childhood Arthritis
11/7/2011
-
Novo Nordisk A/S: Degludecplus Provides Superior Glycaemic Control Compared to Insulin Glargine in a Phase 3a Trial in Japanese People with Type 2 Diabetes
11/7/2011
-
Genentech Release: Data Showed ACTEMRA Monotherapy Significantly Improved Signs and Symptoms of Rheumatoid Arthritis
11/7/2011
-
Eyetech Inc. Release: Post-Hoc Analysis of V.I.S.I.O.N. Trial Data Showed No Association Between Macugen(R) (Pegaptanib Sodium) and Sustained Elevated Intraocular Pressure
11/7/2011
-
Amgen Release: Prolia(R) (denosumab) Open-Label Extension Trial Showed Continued Increase in Bone Mineral Density Over Six Years With Similar Safety Profile Observed in Original Fracture Trial
11/7/2011
-
Abbott Laboratories Announces New Long-Term Data Evaluating Use of HUMIRA(R) (Adalimumab) for Patients with Long-Standing Moderate to Severe Rheumatoid Arthritis and for Patients with Early Moderate to Severe RA
11/7/2011
-
UCB, Inc. Release: New Data From REALISTIC Study Showed Cimzia(R) (certolizumab pegol) Provided Rapid and Sustained Efficacy, Over 28 Weeks, in a Broad Population of Patients With Moderate to Severe Rheumatoid Arthritis (RA) Including Those Who Discontinu
11/7/2011
-
Iroko Pharmaceuticals Release: Pain Medicines in Novel Formulations Show Potential for Relief at Lower Doses
11/7/2011